Berlin - Delayed Quote • EUR
Halozyme Therapeutics Inc (RV7.BE)
At close: April 25 at 8:08 AM GMT+2
Loading Chart for RV7.BE
DELL
- Previous Close
36.55 - Open
36.26 - Bid 35.78 x --
- Ask 35.89 x --
- Day's Range
36.26 - 36.26 - 52 Week Range
27.41 - 41.60 - Volume
133 - Avg. Volume
2 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 7, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: RV7.BE
Performance Overview: RV7.BE
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
RV7.BE
8.60%
S&P 500
5.84%
1-Year Return
RV7.BE
16.97%
S&P 500
22.03%
3-Year Return
RV7.BE
11.52%
S&P 500
20.77%
5-Year Return
RV7.BE
151.35%
S&P 500
72.46%
Compare To: RV7.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap undefined -
Industry -
Mkt Cap undefined -
Industry -
Statistics: RV7.BE
Valuation Measures
As of 4/25/2024
Market Cap
4.64B
Enterprise Value
5.73B
Trailing P/E
18.63
Forward P/E
12.79
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.33
Price/Book (mrq)
59.30
Enterprise Value/Revenue
6.91
Enterprise Value/EBITDA
12.68
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Company Insights: RV7.BE
RV7.BE does not have Company Insights